Letter: Immunodeficiency and epilepsy.
D000293:Adolescent; D000328:Adult; D000361:Agammaglobulinemia / Q000139:chemically induced*; D001327:Autoimmune Diseases / Q000139:chemically induced; D002648:Child; D004406:Dysgammaglobulinemia / Q000139:chemically induced*; D004827:Epilepsy / Q000188:drug therapy; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis*; D007071:Immunoglobulin A, Secretory / Q000032:analysis*; D007153:Immunologic Deficiency Syndromes / Q000139:chemically induced*; D008875:Middle Aged; D010672:Phenytoin / Q000009:adverse effects* / Q000627:therapeutic use
D007070:Immunoglobulin A; D007071:Immunoglobulin A, Secretory; D010672:Phenytoin